Close Menu

NEW YORK (GenomeWeb) – Immunodiagnostic firm Singulex said today that it closed a $50 million senior secured debt facility with Perceptive Advisors. The firm plans to use the financing to continue to develop its single-molecule counting technology that detects disease-associated biomarkers.

Cantor Fitzgerald acted as exclusive financial advisor and sole placement agent to Singulex.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.

Sep
30
Sponsored by
LGC SeraCare Life Sciences

Non-invasive prenatal testing (NIPT) continues to expand globally to support maternal-fetal patient care. 

Oct
09
Sponsored by
PerkinElmer

As cases of COVID-19 continued to grow this spring and summer in the US, so too did the number of Emergency Use Authorizations from the FDA for clinical diagnostic tests aimed at detecting current and past infections.